Medi Caps Ltd

₹ 36.1 -1.85%

19 Nov - close price

About

Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals^[1]

Key Points

Business Overview:^[1]
MCL operates in real estate as a parent company and pharma division through its wholly owned subsidiary. The company entered the real estate segment for city centric developments by way of Land acquisition and developing premium residential and commercial properties. It has almost completed its first project Medicaps Business Park and also sold ~50% of shops in the project

Website BSE

Market Cap ₹ 45.0 Cr.
Current Price ₹ 36.1
High / Low ₹ 61.0 / 34.3
Stock P/E
Book Value ₹ 93.5
Dividend Yield 0.00 %
ROCE -2.12 %
ROE -1.94 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 0.39 times its book value

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -9.96% over past five years.
Company has a low return on equity of -0.99% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	15.37	11.04	10.57	6.38	6.03	7.07	7.87	6.20	8.29	4.02	6.97	2.69	2.02
	13.60	9.37	9.80	7.11	5.53	6.37	8.37	6.48	7.84	5.80	7.20	6.07	4.93
Operating Profit	1.77	1.67	0.77	-0.73	0.50	0.70	-0.50	-0.28	0.45	-1.78	-0.23	-3.38	-2.91
OPM %	11.52%	15.13%	7.28%	-11.44%	8.29%	9.90%	-6.35%	-4.52%	5.43%	-44.28%	-3.30%	-125.65%	-144.06%
	0.89	0.13	0.23	0.07	0.07	0.09	0.24	0.15	0.29	0.16	2.14	0.33	1.53
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.00
Depreciation	0.52	0.50	0.22	0.45	0.45	0.45	0.33	0.43	0.43	0.43	0.44	0.44	0.44
Profit before tax	2.14	1.30	0.78	-1.11	0.12	0.34	-0.59	-0.56	0.31	-2.05	1.45	-3.50	-1.82
Tax %	0.00%	203.08%	53.85%	0.00%	0.00%	150.00%	83.05%	0.00%	0.00%	0.00%	-18.62%	0.00%	0.00%
	2.14	-1.34	0.36	-1.11	0.12	-0.16	-1.08	-0.56	0.31	-2.05	1.72	-3.49	-1.82
EPS in Rs	1.72	-1.07	0.29	-0.89	0.10	-0.13	-0.87	-0.45	0.25	-1.64	1.38	-2.80	-1.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	37.49	36.11	42.97	44.04	53.70	51.79	43.05	58.72	69.87	49.37	27.35	25.48	15.70
	33.78	36.19	40.36	42.43	51.53	47.07	49.80	46.44	59.80	44.18	27.35	27.28	24.00
Operating Profit	3.71	-0.08	2.61	1.61	2.17	4.72	-6.75	12.28	10.07	5.19	0.00	-1.80	-8.30
OPM %	9.90%	-0.22%	6.07%	3.66%	4.04%	9.11%	-15.68%	20.91%	14.41%	10.51%	0.00%	-7.06%	-52.87%
	-1.18	1.29	0.68	2.02	1.07	2.73	2.86	0.46	1.95	1.49	0.48	2.73	4.16
Interest	1.16	0.66	0.06	0.10	0.10	0.13	0.12	0.10	0.11	0.13	0.04	0.05	0.03
Depreciation	2.07	1.81	1.80	1.81	1.79	1.82	1.83	1.52	1.81	1.74	1.69	1.72	1.75
Profit before tax	-0.70	-1.26	1.43	1.72	1.35	5.50	-5.84	11.12	10.10	4.81	-1.25	-0.84	-5.92
Tax %	155.71%	63.49%	39.16%	20.35%	14.81%	2.18%	0.17%	-0.09%	0.10%	63.62%	80.00%	-32.14%
	-1.79	-2.06	0.86	1.37	1.15	5.39	-5.85	11.13	10.08	1.76	-2.24	-0.57	-5.64
EPS in Rs	-1.04	-1.65	0.69	1.10	0.92	4.32	-4.69	8.93	8.08	1.41	-1.80	-0.46	-4.52
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-3%
5 Years:	-10%
3 Years:	-29%
TTM:	-47%

Compounded Profit Growth
10 Years:	-1%
5 Years:	10%
3 Years:	%
TTM:	-279%

Stock Price CAGR
10 Years:	5%
5 Years:	10%
3 Years:	-7%
1 Year:	-29%

Return on Equity
10 Years:	2%
5 Years:	3%
3 Years:	-1%
Last Year:	-2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47
Reserves	71.00	68.94	69.80	76.62	77.75	83.13	78.48	92.24	103.79	106.10	108.51	108.81	104.14
	8.87	0.81	0.08	0.09	0.17	0.12	0.06	0.00	0.00	0.00	0.00	0.00	0.00
	9.60	7.00	10.68	8.19	10.52	10.89	4.20	10.11	14.09	7.42	6.31	4.14	4.65
Total Liabilities	101.94	89.22	93.03	97.37	100.91	106.61	95.21	114.82	130.35	125.99	127.29	125.42	121.26
	36.92	58.05	56.41	62.14	61.03	59.80	57.30	58.12	59.31	58.91	58.65	57.18	56.07
CWIP	0.10	0.00	0.00	0.00	0.00	0.00	0.97	0.54	0.24	0.00	0.00	0.08	0.08
Investments	33.72	5.43	6.74	7.83	11.18	16.35	21.97	29.41	30.67	32.07	38.38	43.04	41.96
	31.20	25.74	29.88	27.40	28.70	30.46	14.97	26.75	40.13	35.01	30.26	25.12	23.15
Total Assets	101.94	89.22	93.03	97.37	100.91	106.61	95.21	114.82	130.35	125.99	127.29	125.42	121.26

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-1.50	7.05	2.59	4.02	4.20	5.96	4.63	15.32	7.02	-6.08	6.94	5.07
	1.54	-6.97	-1.47	2.57	-4.09	-5.75	-5.80	-9.70	-4.08	-2.56	-7.73	-4.98
	0.00	0.00	-0.73	-5.76	0.08	-0.05	-0.06	-0.06	0.00	0.00	0.00	0.00
Net Cash Flow	0.04	0.08	0.39	0.83	0.20	0.16	-1.23	5.56	2.95	-8.64	-0.79	0.09

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	111.96	87.33	82.48	74.09	88.57	90.56	37.39	39.72	52.61	62.55	144.40	125.92
Inventory Days	235.89	265.71	257.13	230.21	148.16	163.52	75.29	93.95	156.60	121.72	243.05	120.79
Days Payable	52.74	66.33	101.86	75.75	90.99	96.26	26.94	86.24	154.35	48.72	77.49	59.64
Cash Conversion Cycle	295.12	286.71	237.75	228.56	145.73	157.82	85.74	47.42	54.85	135.55	309.96	187.06
Working Capital Days	182.65	184.07	154.26	147.11	113.17	127.42	84.70	63.96	87.66	200.50	324.16	304.12
ROCE %	0.44%	-0.69%	1.81%	1.48%	1.56%	5.77%	-6.58%	11.59%	8.78%	3.70%	-1.17%	-2.12%

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	50.13%	50.13%	50.13%	50.13%	50.13%	50.13%	50.13%	50.42%	50.61%	50.76%	50.76%	50.76%
	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
	49.85%	49.84%	49.83%	49.84%	49.85%	49.84%	49.83%	49.54%	49.35%	49.21%	49.21%	49.19%
No. of Shareholders	16,114	15,308	14,566	13,790	13,226	12,356	11,738	11,255	11,176	11,033	10,851	10,692

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
	50.14%	50.14%	50.14%	50.17%	50.14%	50.13%	50.13%	50.13%	50.76%	50.76%
	0.27%	0.26%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
	49.59%	49.60%	49.84%	49.80%	49.83%	49.84%	49.84%	49.84%	49.21%	49.19%
No. of Shareholders	4,262	4,173	4,127	3,963	4,068	18,197	15,308	12,356	11,033	10,692

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Medi Caps Ltd

Medi Caps Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports